{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:06:54Z","timestamp":1780330014189,"version":"3.54.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"vor","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.medj.2024.01.009","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T10:40:49Z","timestamp":1709894449000},"page":"179-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["How early can we treat migraine attacks? A perspective based on prodrome"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4536-9974","authenticated-orcid":false,"given":"Hsiangkuo","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Silberstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2024.01.009_bib1","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/S0140-6736(23)01683-5","article-title":"Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA","volume":"402","author":"Dodick","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2024.01.009_bib2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.25697","article-title":"Longitudinal Neuroimaging over 30 Days: Temporal Characteristics of Migraine","volume":"87","author":"Schulte","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.medj.2024.01.009_bib3","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/brain\/awt320","article-title":"Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks","volume":"137","author":"Maniyar","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.medj.2024.01.009_bib4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/03331024211040467","article-title":"Salivary CGRP can monitor the different migraine phases: CGRP (in)dependent attacks","volume":"42","author":"Alpuente","year":"2022","journal-title":"Cephalalgia"},{"key":"10.1016\/j.medj.2024.01.009_bib5","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1097\/j.pain.0000000000000702","article-title":"Premonitory and nonheadache symptoms induced by CGRP and PACAP38 in patients with migraine","volume":"157","author":"Guo","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.medj.2024.01.009_bib6","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1136\/bmj.284.6320.944","article-title":"Domperidone in the prevention of complete classical migraine","volume":"284","author":"Waelkens","year":"1982","journal-title":"Br. Med. J."},{"key":"10.1016\/j.medj.2024.01.009_bib7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1046\/j.1468-2982.2000.00030.x","article-title":"Prevention of migraine during prodrome with naratriptan","volume":"20","author":"Luciani","year":"2000","journal-title":"Cephalalgia"},{"key":"10.1016\/j.medj.2024.01.009_bib8","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1526-4610.2011.02054.x","article-title":"Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications","volume":"52","author":"Cady","year":"2012","journal-title":"Headache"},{"key":"10.1016\/j.medj.2024.01.009_bib9","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1526-4610.2009.01429.x","article-title":"Revisiting the efficacy of sumatriptan therapy during the aura phase of migraine","volume":"49","author":"Aurora","year":"2009","journal-title":"Headache"},{"key":"10.1016\/j.medj.2024.01.009_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/2515816320944928","article-title":"Early use of acute medication for preventing migraine attacks: Results from a diary-based cohort study","volume":"3","author":"Termini","year":"2020","journal-title":"Cephalalgia Reports"}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634024000394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634024000394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:56:57Z","timestamp":1763002617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666634024000394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2666634024000394"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2024.01.009","relation":{},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How early can we treat migraine attacks? A perspective based on prodrome","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2024.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}